Silk Road Medical Performance

SILKDelisted Stock  USD 27.49  0.00  0.00%   
The entity has a beta of 0.0115, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Silk Road's returns are expected to increase less than the market. However, during the bear market, the loss of holding Silk Road is expected to be smaller as well. Silk Road Medical right now has a risk of 0.0%. Please validate Silk Road maximum drawdown, as well as the relationship between the expected short fall and day typical price , to decide if Silk Road will be following its existing price patterns.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silk Road Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent essential indicators, Silk Road is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors. ...more
Begin Period Cash Flow55.4 M
  

Silk Road Relative Risk vs. Return Landscape

If you would invest  2,749  in Silk Road Medical on October 3, 2024 and sell it today you would earn a total of  0.00  from holding Silk Road Medical or generate 0.0% return on investment over 90 days. Silk Road Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Silk, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Silk Road Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Silk Road's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Silk Road Medical, and traders can use it to determine the average amount a Silk Road's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
SILK
Based on monthly moving average Silk Road is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Silk Road by adding Silk Road to a well-diversified portfolio.

Silk Road Fundamentals Growth

Silk Stock prices reflect investors' perceptions of the future prospects and financial health of Silk Road, and Silk Road fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Silk Stock performance.

About Silk Road Performance

By examining Silk Road's fundamental ratios, stakeholders can obtain critical insights into Silk Road's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Silk Road is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Silk Road Medical, Inc. operates as a medical device company in the United States. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Silk Road operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people.

Things to note about Silk Road Medical performance evaluation

Checking the ongoing alerts about Silk Road for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Silk Road Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Silk Road Medical is not yet fully synchronised with the market data
Silk Road Medical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 177.13 M. Net Loss for the year was (55.74 M) with profit before overhead, payroll, taxes, and interest of 100.76 M.
Silk Road Medical currently holds about 108.87 M in cash with (32.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09.
Over 97.0% of the company shares are owned by institutional investors
Evaluating Silk Road's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Silk Road's stock performance include:
  • Analyzing Silk Road's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Silk Road's stock is overvalued or undervalued compared to its peers.
  • Examining Silk Road's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Silk Road's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Silk Road's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Silk Road's stock. These opinions can provide insight into Silk Road's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Silk Road's stock performance is not an exact science, and many factors can impact Silk Road's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Silk Stock

If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data